Evaluation of amantadine in chronic hepatitis C: A meta-analysis.

被引：0
|
作者：
Deltenre, P
Henrion, J
Canva, V
Texier, F
Louvet, A
de Maeght, S
Paris, JC
Mathurin, P
机构：
[1] Hop Jolimont, Haine St Paul, Belgium
[2] CHRU Lille, Hop Claude Huriez, Lille, France
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：386A / 387A
页数：2
相关论文
共 50 条
  • [31] The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C
    Nakamura, H
    Uyama, H
    Enomoto, H
    Kishima, Y
    Yamamoto, M
    Yoshida, K
    Okuda, Y
    Hirotani, T
    Kuroda, T
    Ito, H
    Matsuda, M
    Terabayashi, M
    Noguchi, S
    HEPATO-GASTROENTEROLOGY, 2003, 50 (49) : 222 - 226
  • [32] The Clinical Efficacy and Adverse Effects of Interferon Combined with Matrine in Chronic hepatitis B: A Systematic Review and Meta-Analysis.
    Wang, Xiaotong
    Lin, Haixiong
    Zhang, Ren
    PHYTOTHERAPY RESEARCH, 2017, 31 (06) : 849 - 857
  • [33] Combination therapy with amantadine and interferon in naive patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials
    Mangia, A
    Leandro, G
    Helbling, B
    Renner, EL
    Tabone, M
    Sidoli, L
    Caronia, S
    Foster, GR
    Zeuzem, S
    Berg, T
    Di Marco, V
    Cino, N
    Andriulli, A
    JOURNAL OF HEPATOLOGY, 2004, 40 (03) : 478 - 483
  • [34] Chronic HCV infection causes insulin resistance - a meta-analysis.
    Jalil, Sajid
    Mummadi, Rajasekhara R.
    Sood, Gagan K.
    GASTROENTEROLOGY, 2007, 132 (04) : A784 - A784
  • [35] Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine
    Pérez-Alvarez, R
    Pérez-López, R
    Lombraña, JLS
    Rodríguez, M
    Rodrigo, L
    JOURNAL OF VIRAL HEPATITIS, 2002, 9 (01) : 75 - 79
  • [36] Practical meta-analysis.
    Chechile, RA
    JOURNAL OF MATHEMATICAL PSYCHOLOGY, 2001, 45 (05) : 791 - 791
  • [37] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C
    Zobair M. Younossi
    Arthur C. McCullough
    David S. Barnes
    Anthony Post
    Janus P. Ong
    Robert O’shea
    Lisa M. Martin
    Diane Bringman
    Denise Farmer
    Gavin Levinthal
    Kevin D. Mullen
    William D. Carey
    Anthony S. Tavill
    Roy Ferguson
    Terry Gramlich
    Digestive Diseases and Sciences, 2005, 50 : 970 - 975
  • [38] Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C
    Younossi, ZM
    McCullough, A
    Barnes, D
    Post, A
    Ong, J
    O'Shea, R
    Martin, LM
    Bringman, D
    Farmer, D
    Levinthal, G
    Mullen, KD
    Carey, WD
    Tavill, AS
    Ferguson, R
    Gramlich, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (05) : 970 - 975
  • [39] Telaprevir for Chronic Hepatitis C with Genotype 1: A Meta-Analysis
    Dang, Shuang-Suo
    Wang, Wen-Jun
    Wang, Xiu-Fang
    Li, Ya-Ping
    Li, Mei
    Jia, Xiao-Li
    Wang, Yuan
    Liu, Enqi
    Zhao, Sihai
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 461 - 468
  • [40] Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C
    Khalili, M
    Denham, C
    Perrillo, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (05): : 1284 - 1289
12345